New Suggestions In Sublingual Immunotherapy for House Dust Mite-Related Allergic Diseases.
CONCLUSION: The favorable efficacy and safety profile of MK-8237 HDM-SLIT tablets provided a consolidated therapeutic option for patients with HDM-induced allergic rhinitis and asthma.
PMID: 28413977 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Ferrando M, Bagnasco D, Passa-Lacqua G, Puggioni F, Varricchi G, Canonica GW Tags: Curr Pharm Biotechnol Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Biotechnology | Clinical Trials | Corticosteroid Therapy | Hay Fever | Immunotherapy